Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,229 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete Remission.
Steiner N, Massoud R, Richter J, Perekhrestenko T, Gagelmann N, Niederwieser C, Rathje K, Lastovytska I, Schäfersküpper M, Heidenreich S, Rudolph I, Zeck G, Janson D, Wolschke C, Ayuk FA, Klyuchnikov E, Kröger N. Steiner N, et al. Among authors: richter j. Eur J Haematol. 2024 Sep 19. doi: 10.1111/ejh.14305. Online ahead of print. Eur J Haematol. 2024. PMID: 39300830
Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of life.
Braun B, Fischbach F, Richter J, Pfeffer LK, Fay H, Reinhardt S, Friese MA, Stellmann JP, Kröger NM, Heesen C, Häußler V. Braun B, et al. Among authors: richter j. Mult Scler Relat Disord. 2024 Feb;82:105414. doi: 10.1016/j.msard.2023.105414. Epub 2023 Dec 27. Mult Scler Relat Disord. 2024. PMID: 38176284 Free article.
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantation.
Oechsler S, Gagelmann N, Wolschke C, Janson D, Badbaran A, Klyuchnikov E, Massoud R, Rathje K, Richter J, Schäfersküpper M, Niederwieser C, Kunte A, Heidenreich S, Ayuk F, Kröger N. Oechsler S, et al. Among authors: richter j. Bone Marrow Transplant. 2024 Apr;59(4):550-557. doi: 10.1038/s41409-024-02220-7. Epub 2024 Feb 6. Bone Marrow Transplant. 2024. PMID: 38321269 Free PMC article.
Anti-T-lymphocyte globulin (ATLG) compared to post-transplant cyclophosphamide as GvHD prophylaxis in ALL patients undergoing allogeneic stem cell transplantation.
Steiner N, Massoud R, Klyuchnikov E, Gagelmann N, Richter J, Niederwieser C, Rathje K, Urbanowicz T, Kunte A, Engelmann J, Ihne C, Lastovytska I, Lindhauer C, Marquard F, Reichard M, Ryzhkova A, Sabauri R, Schäfersküpper M, Seyedi N, Kalogeropoulos G, Heidenreich S, Rudolph I, Zeck G, Janson D, Wolschke C, Ayuk F, Kröger N. Steiner N, et al. Among authors: richter j. Bone Marrow Transplant. 2024 Sep;59(9):1265-1274. doi: 10.1038/s41409-024-02328-w. Epub 2024 Jun 14. Bone Marrow Transplant. 2024. PMID: 38877098 Free PMC article.
CAR-T cell therapy embarks on autoimmune disease.
Rampotas A, Richter J, Isenberg D, Roddie C. Rampotas A, et al. Among authors: richter j. Bone Marrow Transplant. 2024 Oct 8. doi: 10.1038/s41409-024-02429-6. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 39379698 Review. No abstract available.
Association of Childhood Abuse with Incident Inflammatory Bowel Disease.
Anyane-Yeboa A, Casey K, Roberts AL, Lopes E, Burke K, Ananthakrishnan A, Richter J, Cozier YC, Koenen KC, Chan AT, Khalili H. Anyane-Yeboa A, et al. Among authors: richter j. Clin Transl Gastroenterol. 2024 Oct 25. doi: 10.14309/ctg.0000000000000718. Online ahead of print. Clin Transl Gastroenterol. 2024. PMID: 39450870
3,229 results